Transforming Cancer Care Delivery With Generative AI
Artificial intelligence (AI) is poised to transform cancer care delivery from diagnosis to treatment selection, and even the communication between physicians and patients.
FEATURED BLOGS
Blog
Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
The Potential of AI in Clinical ResearchNov 20, 2023 "We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients."
Millions of people have been affected by the war in Sudan, and the outlook for patients with cancer is particularly dire. Dr. Nabeeha Karadawi, Dr. Salma Awad Elkareem Ali Mohamed, and Nagham Ali outline the current situation and call for immediate international aid.
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
Advertisement
Latest Comments & Discussions
Nov 28, 2023
After 10 years in practice, I took the high stakes 10 year recertification exam that I paid for. I was disappointed to find out that...
William Bruce
Nov 23, 2023
Hi, My name is william bruce, thanks for sharing this nformation. I'm truly inspired by the dedication and expertise of oncologists....
Ahmed M. Elzawawy, MD, PhD
Jul 12, 2023
Dear Dr. Lynn M. Schuchter our President of ASCO and all colleagues the members of ASCO ,
Please read this message entitled...
Ahmed M. Elzawawy, MD, PhD
Jul 12, 2023
Topic: There is a great need for game changing in global oncology
Dear our President of ASCO,
A few months ago , I was reading...
Patti B. Beaver, MSN
Jun 25, 2023
I was shocked and saddened to learn of Dr. Blackstock's passing. He was full of life and uniquely able to find appropriate humor...
Most Read
Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
Artificial intelligence (AI) is poised to transform cancer care delivery from diagnosis to treatment selection, and even the communication between physicians and patients.
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
At a time when we are being asked, in every aspect of our work, to do more with less, we can expect streamlined, efficient, pragmatically designed clinical trials to play an increasingly important role in our research enterprise.
Jeff Porter Sharman, MD